THE PAIN BLOCK™ SYSTEM

Innovativa läkemedelför lokal smärtblockering på huden

Vetenskapsbaserad topikal teknologi utvecklad för lokal och riktad behandling direkt där smärtan och irritationen uppstår.

Innovative medicines

A Swedish innovation with global potential

Auxesis Pharma is approaching commercialization. With patented technology, a growing product portfolio and upcoming local manufacturing in Sweden, we are building a long-term path to the global market.

For investors, this is a unique opportunity to join the journey as Swedish drug development meets international demand. We combine scientifically validated effect with a scalable business model, positioning Auxesis Pharma as a future player in innovative medicines.

Innovation

Innovation and product development

Swedish drug development with the skin in focus

We have succeeded in stabilizing acetylsalicylic acid in liquid form — a solution long considered impossible...

Behind our medicines is a Swedish team...

Topical Platform Technology

Skin pain should be treated where it occurs

Auxesis Pharma develops topical treatments designed to act directly at the source of pain and irritation in the skin.

Our technology is based on a stabilized liquid form of acetylsalicylic acid, developed for precise local application without unnecessary systemic exposure.

The platform forms the foundation for ASA.P® and several future products within human medicine, aesthetic dermatology, cosmeceuticals and veterinary medicine.

Topical application of ASA.P®
The first product on the platform

ASA.P® – local treatment of skin pain

ASA.P® is the first product being developed on Auxesis Pharma’s topical technology platform. It is designed to treat pain and irritation directly in the affected area of the skin.

The stabilized liquid form of ASA penetrates locally, reaches and blocks COX signals at the source of pain and remains where it is needed.

  • Local application directly to the skin
  • Non-systemic action
  • Targeted treatment at the source of pain
  • Developed for rapid effect
Discover ASA.P®
Development Pipeline

More innovations are on the way

Auxesis Pharma continues to develop the next generation of topical innovations in dermatology, aesthetic medicine, and veterinary medicine.

Dermexa™Cutivelle™Lenvée™CoxyPet®
Explore our pipeline
Skin areas

Different types of skin pain

ASA.P® is being developed to block pain signals locally in the skin and treat pain and irritation where they occur.

Wasp stings
0106
Lokal hudsmärta

Wasp stings

Wasp stings can cause intense local pain, a burning sensation, swelling and redness.

News

Latest from Auxesis Pharma

Dermatologi – nytt kompletterande affärsområde
2026/07/22

Dermatologi – nytt kompletterande affärsområde

Read more
En historisk milstolpe för Auxesis Pharma
2026-07-03

En historisk milstolpe för Auxesis Pharma

Read more
Auxesis Pharma stärker styrelsen med tre nya ledamöter
2026-06-12

Auxesis Pharma stärker styrelsen med tre nya ledamöter

Read more